A tech company developing the world’s first non-invasive wearable blood glucose sensor has been hailed as an “innovation success story” by the Wales Director of the CBI. Ian Price said Afon Technology, based in Caldicot, was boosting economic growth in the country by creating high-skilled jobs with its pursuit of creating the holy grail of diabetes monitoring. Scientists at Afon have been creating a real-time and continuous glucose sensor, tipped to completely transform the lives of those by completely removing needles from the process of monitoring blood sugar levels. The sensor sits on the i ..read more

Individuals with type 2 diabetes are more likely to develop breast and bowel cancers compared to people living without the condition, latest evidence reveals. In the UK, cancer is now the most common cause of death among people with diabetes. Despite this, people with diabetes are less likely to participate in cancer screening which can improve survival from the disease. Researchers at Leeds Beckett University spoke to people aged 50 to 74 in the UK to find out if they are aware that type 2 diabetes increases the risk of breast and bowel cancer. The researchers also reviewed the top-ranking di ..read more

Updated guidance on how finerenone can treat chronic kidney disease in people with type 2 diabetes will be published next week by the National Institute for Health and Care Excellence. This new guideline will appraise the clinical and cost effectiveness of finerenone within its marketing authorisation for treating chronic kidney disease in people living with type 2 diabetes. According to the National Institute for Health and Care Excellence (NICE), the expected publication date of the document is Thursday, March 23. For more information on the guideline ‘Finerone for treating chronic kidney di ..read more

More than 70 per cent of people living with diabetes believe that advanced insulin delivery systems are ‘very useful’ in helping them manage their condition, latest research indicates. A team of scientists have found that the cognitive burden associated with self-management of diabetes therapy may influence preferences for insulin injection devices. New insulin delivery devices feature connectivity, enabling data transfer to phone applications to provide decision support and reduce errors in dosing and timing, while also reducing cognitive burdens. The research team conducted an online survey ..read more

New guidance covering the care and treatment for adults with type 2 diabetes is now available to access thanks to NICE.  Within the guideline, the national health organisation has listed the care areas that should be prioritised for improvement. The review identified: Changes in the priority areas for improvement New and updated guidance on type 2 diabetes in adults That the quality standard on diabetes in adults should be split into separate quality standards on type 1 diabetes in adults and type 2 diabetes in adults. This guideline was originally published in March 2011. The document ..read more

A drug used to help individuals lose weight will soon be available to thousands of people through the NHS. People can reduce their body weight by more than 10 per cent if they start taking semaglutide alongside living a healthy lifestyle. Also known as Wegovy, semaglutide will be available for people with an BMI of above 30kg/m2, with one weight-related comorbidity and who are eligible for referral to specialist weight management services. A weight-related comorbidity includes type 2 diabetes, hypertension, cardiovascular disease, dysglycaemia, prediabetes, obstructive sleep apnoea and dyslipi ..read more

A recognised diabetes charity is inviting healthcare professionals to attend its first ever national wellness day in September as it marks 25 years since the organisation was formed. The Diabetes Research and Wellness Foundation (DRWF) is celebrating 25 years in business by hosting a wellness day for the diabetes community. Entitled ‘United Through Diabetes’, the event will take place on Saturday, September 16, at Chesford Grange in Kenilworth, Warwickshire. The day will bring experts together from across the entire diabetes community to share their knowledge, expertise, practical skills, pers ..read more

Young people with newly diagnosed type 1 diabetes who intensively manage their diabetes achieve better glucose control, latest evidence suggests. New research has found that automated insulin delivery is beneficial for glucose control; however, it does not affect the decline in pancreatic C-peptide secretion. During the randomised clinical trial, 113 youths aged between seven and 17 with newly diagnosed type 1 diabetes were analysed. Each participant was randomly assigned to one of two diabetes management programmes, with half the group using an automated insulin delivery system and the other ..read more

The NICE guideline which covers the care and treatment for adults with type 1 diabetes has been updated.  According to the national health organisation, the revised guidance describes high-quality care in priority areas for improvement. It does not cover diabetes in children and young people, diabetes in pregnancy or other types of diabetes in adults. The updates include: Changes in the priority areas for improvement New and updated guidance on type 1 diabetes in adults That the quality standard on diabetes in adults should be split into separate quality standards on type 1 diabetes in a ..read more

A glittering line-up of leading healthcare professionals will form part of the exciting agenda for the Trend Diabetes national conferences. Taking place on Friday, June 9, at the Thistle Hotel Marble Arch in London, on Friday, June 16, at the National Conference Centre in Birmingham and then again on Friday, June 23, at the Hilton in Newcastle, the in-person events will address some of the leading topics in diabetes care. Entitled ‘Diabetes: Does your sex matter’, the conferences will include the same content and aim to support diabetes healthcare professionals by sharing best p ..read more